On Nov 8, 2021 GeneCentric Therapeutics closed a Series B round and raised $7,500,000 from Alexandria Venture Investments, Hatteras Venture Partners, IAG Capital Partners, LabCorp, featuring lead investors .
About the company: GeneCentric Therapeutics is located at United States, North America.
“”
Company website: http://www.genecentric.com